Latest News

Uniper SE recently reported its full-year 2025 results, with sales of €61,283 million versus €69,978 million a year earlier and net income of €1,397 million compared with €297 million, lifting basic earnings per share from continuing operations to €3.35 from €0.71. The sharp rise in net income despite lower sales highlights a marked improvement in profitability, which raises questions about the sustainability and drivers of this performance shift. We will now examine how this substantial...

Why Dekon Food and Agriculture Group’s Latest Earnings Matter Dekon Food and Agriculture Group (SEHK:2419) has just posted its full year 2025 results, reporting sales of CNY 23,159.02 million and a sharp year-on-year fall in net income and earnings per share. See our latest analysis for Dekon Food and Agriculture Group. Investors reacted to the weaker earnings, but the stock still shows momentum, with a 1-day share price return of 2.20%, a 30-day share price return of 9.66%, and a 1-year...

Wondering if Rezolve AI at US$2.53 is still priced for a turnaround or already baking in the story? This breakdown will help you frame what the current market price may be implying. The stock has been volatile recently, with a 5.9% decline over the last week, a 13.5% gain over the last month, an 11.8% year to date drop, and a 53.3% return over the past year, all set against a 74.9% decline over three years. Recent coverage has focused on Rezolve AI as an emerging player in the listed AI...

Samsonite Group (SEHK:1910) has wrapped up FY 2025 with fourth quarter revenue of US$963.3 million and basic EPS of US$0.07, while trailing twelve month revenue came in at about US$3.5 billion with EPS of roughly US$0.21. Over the past few quarters, revenue has ranged from US$796.6 million to US$963.3 million and quarterly EPS has moved between US$0.04 and US$0.07, giving investors a clear read on how sales and earnings are tracking into the current pricing of HK$15.21. With trailing net...

China Beststudy Education Group (SEHK:3978) has reported its FY 2025 first half results with revenue of C¥917.1 million and basic EPS of C¥0.199. Its trailing twelve month figures stand at C¥1.9 billion in revenue and C¥0.396 in EPS, giving investors a clearer view of the recent earnings run rate. The company has seen revenue move from C¥317.4 million and EPS of C¥0.072 in 1H FY 2024 to C¥784.6 million and EPS of C¥0.184 in 2H FY 2024, and now to C¥917.1 million and EPS of C¥0.199 in 1H FY...

Starwood Real Estate Income Trust (OTCPK:SWDR) has posted its FY 2025 numbers with fourth quarter revenue of US$402.8 million, a basic EPS loss of US$0.39, and funds from operations of US$4.4 million in the red, setting the tone for a year where trailing twelve month revenue reached about US$1.6 billion alongside a net loss of US$691.6 million. Over recent quarters, revenue has moved in a tight band between US$389.7 million and US$420.2 million while EPS has remained in loss territory. As a...

China Hongqiao Group FY 2025 Earnings Snapshot China Hongqiao Group (SEHK:1378) has posted its FY 2025 numbers with second half revenue of C¥81.3b and basic EPS of C¥1.07, while trailing twelve month revenue sits at C¥162.4b and EPS at C¥2.38. Over recent periods, revenue has ranged from C¥82.6b in the second half of 2024 to just over C¥81b in each half of 2025, with basic EPS moving between C¥1.39 and C¥1.07 across those same halves as the full year TTM earnings base has built out. With a...

How Beijing Tong Ren Tang Chinese Medicine's FY 2025 Numbers Set Up the Next Chapter Beijing Tong Ren Tang Chinese Medicine (SEHK:3613) has just posted FY 2025 first half numbers, with revenue of HK$761.7 million and basic EPS of HK$0.28, setting the tone for how investors will read the rest of the year. Over the last three reported halves, revenue has moved from HK$664.5 million in 1H 2024 to HK$947.1 million in 2H 2024 and now HK$761.7 million in 1H 2025, while basic EPS has tracked...

Setting the Scene: Hong Kong and China Gas FY 2025 Results Hong Kong and China Gas (SEHK:3) has put fresh numbers on the table for FY 2025, with first half revenue of HK$27.5 billion and basic EPS of HK$0.16 anchoring the latest set of results. Looking back at recent periods, revenue has held close to HK$27.5 billion across the last three halves, while basic EPS has moved between HK$0.14 and HK$0.16. This gives a clear line of sight on how the top line and per share earnings have been...

In March 2026, Walgreens announced a nationwide initiative with Exact Sciences and Workflow Services that lets eligible, average-risk customers request the FDA-approved, at-home Cologuard colorectal cancer screening test through its pharmacies, aiming to close care gaps with pharmacist-led services integrated into store workflows. At the same time, Exact Sciences highlighted new data on its Oncodetect molecular residual disease test and Cancerguard multi-cancer early detection assay at the...

Shanghai Haohai Biological Technology (SEHK:6826) has wrapped up FY 2025 with fourth quarter revenue of C¥573.9 million and a basic EPS loss of C¥0.23, while the trailing twelve month basic EPS sits at C¥1.08 on revenue of about C¥2.5 billion. Over recent periods the company has seen quarterly revenue move between C¥573.9 million and C¥685.9 million, with basic EPS ranging from a loss of C¥0.23 to a profit of C¥0.52. This presents a mixed earnings picture across the year. With a trailing net...

Taysha Gene Therapies (NasdaqGS:TSHA) received FDA Breakthrough Therapy designation for TSHA-102 in Rett syndrome. The company reported a 100% patient response rate in pivotal Phase I/II data for TSHA-102. Regulators aligned with Taysha on pivotal trial designs for its lead Rett syndrome program. Taysha added a key commercial hire as it prepares for potential TSHA-102 commercialization. Taysha Gene Therapies, trading at $4.4 per share, has been drawing attention as its 1 year return stands...

China Traditional Chinese Medicine Holdings (SEHK:570) has reported its FY 2025 first half results with revenue of C¥7.5b and a basic EPS loss of C¥0.02, while the trailing twelve months show revenue of C¥14.7b and a basic EPS loss of C¥0.07. Over recent half year periods, revenue has moved from C¥8.4b with EPS of C¥0.04 in 1H 2024 to C¥8.1b with an EPS loss of C¥0.03 in 2H 2024, then to C¥7.5b with an EPS loss of C¥0.02 in 1H 2025, setting up a story where investors are weighing weaker...

China Power International Development (SEHK:2380) has released its FY 2025 results with first half revenue of C¥24.7b and basic EPS of C¥0.21, while trailing twelve month revenue sits at C¥53.0b with EPS of C¥0.24. Over recent periods, the company has seen revenue move from C¥27.2b in 1H 2024 to C¥29.1b in 2H 2024 and then C¥24.7b in 1H 2025, alongside basic EPS figures of C¥0.21, C¥0.06 and C¥0.21 respectively. This sets up a picture where modest earnings growth and slightly stronger net...

Tian An China Investments (SEHK:28) has opened FY 2025 with first half revenue of HK$8.7b and basic EPS of HK$1.60, against a backdrop where the trailing twelve months show revenue of HK$10.5b and EPS of HK$1.21 as the company has moved from a prior loss to profit over the last year. Over recent periods, revenue has shifted from HK$1.5b in the first half of FY 2024 to HK$1.5b in the second half, before stepping up to HK$8.7b in the first half of FY 2025. Over the same periods, EPS moved from...

Premier Investments (ASX:PMV) has reported H1 2026 revenue of A$460.6 million and net income of A$101.7 million, with EPS at A$0.64, alongside a trailing 12 month revenue base of A$826.8 million and EPS of A$0.90. Over the last two first half periods, revenue has moved from A$465.7 million in H1 2025 to A$460.6 million in H1 2026, while EPS has edged from A$0.63 to A$0.64. With net profit margin sitting below last year and multi year earnings trends under pressure, the latest result puts the...

Ambarella (NasdaqGS:AMBA) used a recent industry conference to outline a faster push into Edge AI products. The company highlighted a major shift in its revenue mix, new sales efforts aimed at smaller customers, and progress on a semi custom chip. Management also disclosed work on an upcoming two nanometer chip, signaling a move to more advanced manufacturing nodes. Ambarella, trading at about $54.02, has seen a mixed share price record, with a 3.3% gain over the past week but a 28.1%...

Yiren Digital (YRD) is back in focus after Q4 2025 results showed revenue of CN¥957.63 million, a net loss of CN¥882.16 million, and a temporary suspension of its cash dividend for the second half of 2025. See our latest analysis for Yiren Digital. The earnings miss and dividend suspension appear to have weighed heavily on sentiment, with a 7 day share price return of 44.19% and a 1 year total shareholder return of 69.72%. The 3 year total shareholder return remains slightly positive, which...

Earnings snapshot and recent momentum MGM China Holdings (SEHK:2282) has put fresh numbers on the board for FY 2025, with first half revenue of about HK$16.7b, basic EPS of HK$0.63 and net income of HK$2.4b setting the tone for the year. The business has seen revenue move from roughly HK$16.2b in 1H 2024 to HK$15.2b in 2H 2024 and then to HK$16.7b in 1H 2025, while basic EPS shifted from HK$0.71 to HK$0.50 and then HK$0.63 over the same periods. This gives a clear sense of how headline growth...

HeartFlow (NasdaqGS:HTFL) reported landmark real world data at ACC 2026 showing its AI Plaque Analysis as a leading independent predictor for cardiovascular risk stratification. The Plaque Analysis data is linked with improved patient outcomes and substantial cost savings in coronary artery disease management. The company launched the large scale NAVIGATE PCI Registry to study its AI driven PCI Navigator tool ahead of commercial release. HeartFlow’s AI platform is now backed by FDA cleared...

Haidilao International Holding has been named the World’s Strongest Restaurant Brand for 2024. The recognition highlights the company’s brand strength beyond its usual financial headlines. The stock, traded under ticker SEHK:6862, last closed at HK$15.85. For investors tracking SEHK:6862, this brand accolade arrives after a mixed share price record. The stock is up 10.0% year to date, while the 1 year return stands at a 2.6% decline and the 5 year return at a 64.6% decline, with the current...

FedEx Q3 2026 Earnings Snapshot FedEx (FDX) has put up another solid set of quarterly numbers, with Q3 2026 revenue at US$24.0 billion and basic EPS of US$4.47, giving investors a clear look at how the business is performing through the current fiscal year. The company has seen revenue move from US$21.2 billion in Q3 2025 to US$24.0 billion in Q3 2026, while quarterly basic EPS shifted from US$3.78 to US$4.47 over the same period. The trailing twelve month net profit margin now sits at 4.9%...

IONOS Group (XTRA:IOS) is back in focus after reporting full year 2025 results, with revenue of €1,316.89 million and net income of €229.69 million, alongside a marked push into AI supported services. See our latest analysis for IONOS Group. The latest earnings announcement and AI push have been met with a 3.17% 1 day share price return and 7.73% 7 day share price return. However, the year to date share price return of 8.61% and 1 year total shareholder return of 5.06% indicate that longer...

Hexcel is collaborating through the ECCA initiative with James Cropper to develop aerospace grade composites using recycled carbon fibre, supporting circularity and lower waste in advanced materials. The company is also a key materials supplier for Dassault Aviation's Falcon 10X program, which has reached an important aircraft rollout milestone. These developments highlight Hexcel's role in both sustainable material solutions and next generation business jets across the aerospace...